Daniel M. Tennenbaum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel M. Tennenbaum has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Andrew Coleman
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY
8 shared publications - Darren Richard Feldman
Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY
7 shared publications Almedina Redzematovic
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
6 shared publicationsMaria F. Becerra
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
6 shared publications- Abraham Ari Hakimi
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, USA
4 shared publications - James J. Hsieh
Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA
4 shared publications
Latest Publications
- 9 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (4) , 1011-1012
Redo robotic pyeloplasty in pediatric patients: Technical recommendations for a safe and successful procedure
- 9 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (4) , 1011-1012
Redo robotic pyeloplasty in pediatric patients: Technical recommendations for a safe and successful procedure
- 1 July 2019
- Published by Elsevier in European Urology Focus
- Vol. 5 (4) , 642-649
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma
- 1 July 2019
- Published by Elsevier in European Urology Focus
- Vol. 5 (4) , 642-649
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma
- Open Access
- 1 January 2019
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 37 (1) , 12-17
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
- 1 January 2019
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 37 (1) , 12-17
Open AccessCharacterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
- 1 December 2018
- Published by Elsevier in European Urology Focus
- Vol. 4 (6) , 986-994
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
- 1 December 2018
- Published by Elsevier in European Urology Focus
- Vol. 4 (6) , 986-994
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
- 5 December 2017
- Published by Springer Nature in World Journal of Urology
- Vol. 36 (2) , 257-263
Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma
To understand the longitudinal renal function trends in patients undergoing radical nephroureterectomy (RNU) and identify clinicopathologic characteristics associated with estimated glomerular filtration rate (eGFR) recovery.
- 5 December 2017
- Published by Springer Nature in World Journal of Urology
- Vol. 36 (2) , 257-263
Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma
To understand the longitudinal renal function trends in patients undergoing radical nephroureterectomy (RNU) and identify clinicopathologic characteristics associated with estimated glomerular filtration rate (eGFR) recovery.
- 1 December 2017
- Published by Elsevier in European Urology Focus
- Vol. 3 (6) , 590-598
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
- 1 December 2017
- Published by Elsevier in European Urology Focus
- Vol. 3 (6) , 590-598
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
- 1 October 2017
- Published by Elsevier in European Urology Focus
- Vol. 3 (4-5) , 421-427
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
- 1 October 2017
- Published by Elsevier in European Urology Focus
- Vol. 3 (4-5) , 421-427
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
- Open Access
- 1 August 2017
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 35 (8) , 532.e7-532.e13
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
- 1 August 2017
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 35 (8) , 532.e7-532.e13
Open AccessGenomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
- 1 January 2017
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 35 (1) , 35.e1-35.e5
The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models
- 1 January 2017
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 35 (1) , 35.e1-35.e5
The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models